11 August 2022 · Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration